🇺🇸 FDA
Patent

US 9410198

Compostions and methods of nucleic acid-targeting nucleic acids

granted A61KA61K38/465A61K47/549

Quick answer

US patent 9410198 (Compostions and methods of nucleic acid-targeting nucleic acids) held by Caribou Biosciences, Inc. expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Caribou Biosciences, Inc.
Grant date
Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/465, A61K47/549, A61K47/6455, A61P